FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

FB van Gog

Research Profile

Living Beings

Procedures

Concepts & Ideas

Tissue Distribution

Chemicals & Drugs

Disorders

Anatomy

Tumor Cells, Cultured

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
FB van Gog; Gerard W M Visser; R W Gowrising; Gordon B Snow; Guus A M S van Dongen
Synthesis and evaluation of 99mTc/99Tc-MAG3-biotin conjugates for antibody pretargeting strategies.
FB van Gog; Ruud H Brakenhoff; Marijke Stigter-van Walsum; Gordon B Snow; Guus A M S van Dongen
Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer.
E Kievit; FB van Gog; Hennie M M Schlüper; Guus A M S van Dongen; HERBERT PINEDO; Epie Boven
[186Re]-labeled mouse and chimeric monoclonal antibody 323/A3: a comparison of the efficacy in experimental human ovarian cancer.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of FB van Gog (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

1998: FB van Gog; Gerard W M Visser; R W Gowrising; Gordon B Snow; Guus A M S van Dongen
Synthesis and evaluation of 99mTc/99Tc-MAG3-biotin conjugates for antibody pretargeting strategies.
Nuclear medicine and biology 1998;25(7):611-9.
1998: FB van Gog; Ruud H Brakenhoff; Marijke Stigter-van Walsum; Gordon B Snow; Guus A M S van Dongen
Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer.
International journal of cancer. Journal international du cancer 1998;77(1):13-8.
1998: E Kievit; FB van Gog; Hennie M M Schlüper; Guus A M S van Dongen; HERBERT PINEDO; Epie Boven
[186Re]-labeled mouse and chimeric monoclonal antibody 323/A3: a comparison of the efficacy in experimental human ovarian cancer.
Nuclear medicine and biology 1998;25(1):37-45.
1997: FB van Gog; Gerard W M Visser; J W Stroomer; Jan C Roos; Gordon B Snow; Guus A M S van Dongen
High dose rhenium-186-labeling of monoclonal antibodies for clinical application: pitfalls and solutions.
Cancer 1997;80(12 Suppl):2360-70.
1997: E Kievit; FB van Gog; Hennie M M Schlüper; Guus A M S van Dongen; HERBERT PINEDO; Epie Boven
Comparison of the biodistribution and the efficacy of monoclonal antibody 323/A3 labeled with either 131I or 186Re in human ovarian cancer xenografts.
International journal of radiation oncology, biology, physics 1997;38(4):813-23.
1997: FB van Gog; Ruud H Brakenhoff; Gordon B Snow; Guus A M S van Dongen
Rapid elimination of mouse/human chimeric monoclonal antibodies in nude mice.
Cancer immunology, immunotherapy : CII 1997;44(2):103-11.
1997: W E Meijs; Hidde J Haisma; Rob P Klok; FB van Gog; E Kievit; HERBERT PINEDO; J D M Herscheid
Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude mice.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(1):112-8.
1996: Guus A M S van Dongen; R M Brakenhoff; C T ten Brink; FB van Gog; Remco de Bree; Jasper J Quak; Gordon B Snow
Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer.
Anticancer research 1996;16(4C):2409-13.
1996: FB van Gog; Gerard W M Visser; Rob P Klok; R van der Schors; Gordon B Snow; Guus A M S van Dongen
Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(2):352-62.
1995: Ruud H Brakenhoff; FB van Gog; J E Looney; M van Walsum; Gordon B Snow; Guus A M S van Dongen
Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer.
Cancer immunology, immunotherapy : CII 1995;40(3):191-200.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.